Literature DB >> 1822108

Antidepressant therapy in the chronic fatigue syndrome.

S Lynch1, R Seth, S Montgomery.   

Abstract

The chronic fatigue syndrome is a condition receiving increasing recognition. Symptoms of depression are not infrequent and may be persistent and severe enough to warrant treatment. The controversy over the use of antidepressant therapy in this condition may present a dilemma for the general practitioner considering possible treatments. This paper draws on the literature and on the authors' own observations of patients with the chronic fatigue syndrome to suggest guidelines for the use of antidepressant therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822108      PMCID: PMC1371759     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  27 in total

1.  The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia.

Authors:  E D ACHESON
Journal:  Am J Med       Date:  1959-04       Impact factor: 4.965

2.  Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders.

Authors:  S Wessely; R Powell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

3.  What is myalgic encephalomyelitis?

Authors:  A R Lloyd; D Wakefield; C Boughton; J Dwyer
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

Review 4.  Postviral fatigue syndrome.

Authors:  P O Behan; W M Behan
Journal:  Crit Rev Neurobiol       Date:  1988

Review 5.  Postviral fatigue syndrome: time for a new approach.

Authors:  A S David; S Wessely; A J Pelosi
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

6.  Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation.

Authors:  H Moldofsky; P Scarisbrick
Journal:  Psychosom Med       Date:  1976 Jan-Feb       Impact factor: 4.312

7.  Management of chronic (post-viral) fatigue syndrome.

Authors:  S Wessely; A David; S Butler; T Chalder
Journal:  J R Coll Gen Pract       Date:  1989-01

8.  Normal muscle strength and fatigability in patients with effort syndromes.

Authors:  M J Stokes; R G Cooper; R H Edwards
Journal:  BMJ       Date:  1988-10-22

9.  Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.

Authors:  U Baumhackl; K Bizière; R Fischbach; C Geretsegger; G Hebenstreit; E Radmayr; M Stabl
Journal:  Br J Psychiatry Suppl       Date:  1989-10

10.  Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline.

Authors:  R A Scudds; G A McCain; G B Rollman; M Harth
Journal:  J Rheumatol Suppl       Date:  1989-11
View more
  2 in total

1.  Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary.

Authors:  Spencer Richman; Matthew C Morris; Gordon Broderick; Travis J A Craddock; Nancy G Klimas; Mary Ann Fletcher
Journal:  Clin Ther       Date:  2019-03-11       Impact factor: 3.393

Review 2.  Treatment of the chronic fatigue syndrome. A review and practical guide.

Authors:  E Blondel-Hill; S D Shafran
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.